Danny Hart
2015
In 2015, Danny Hart earned a total compensation of $1.3M as Vice President, Business Development at PDL BioPharma, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $611,938 |
|---|---|
| Salary | $370,800 |
| Stock Awards | $304,500 |
| Other | $40,000 |
| Total | $1,327,238 |
Hart received $611.9K in non-equity incentive plan, accounting for 46% of the total pay in 2015.
Hart also received $370.8K in salary, $304.5K in stock awards and $40K in other compensation.
Rankings
In 2015, Danny Hart's compensation ranked 6,564th out of 13,638 executives tracked by ExecPay. In other words, Hart earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,564 out of 13,638 | 52nd |
Division Manufacturing | 2,465 out of 5,187 | 53rd |
Major group Chemicals And Allied Products | 891 out of 1,857 | 52nd |
Industry group Drugs | 714 out of 1,531 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 126 out of 260 | 52nd |
Source: SEC filing on April 28, 2017.
Hart's colleagues
We found five more compensation records of executives who worked with Danny Hart at PDL BioPharma in 2015.